Home » UK's MHRA Amends Clinical Trial Regulations
UK's MHRA Amends Clinical Trial Regulations
August 8, 2006
The Medicines and Healthcare products Regulatory Agency (MHRA), the UK equivalent of the FDA, has amended the country’s clinical trial regulations to bring them into compliance with the European Commission’s Good Clinical Practice (GCP) Directive (Directive 2005/28/EC1).
To View This Article:
Subscribe To International Medical Device Regulatory Monitor